AstraZeneca is presenting a broad package of new clinical and [...]

The Society for RNA Therapeutics (SRT) has expanded its leadership [...]

Glasgow medical technology company Nebu~Flow has secured a £2 million [...]

Evogene has reported positive Phase 1 data for microbiome-based therapy [...]

Phase 3 data presented at ASCO 2026 suggest a PSMA-targeted [...]

Bruker has unveiled new mass spectrometry platforms, software and workflows [...]

Pierre Fabre Laboratories has received a positive opinion from the [...]

Skyhawk Therapeutics has reported encouraging 12-month results from its ongoing [...]

People with extensive-stage small cell lung cancer in England and [...]

Quotient Sciences has begun a Phase 1 clinical study evaluating [...]